ENHANCE, involving 720 patients, began immediately in June 2002 and was modeled on an imaging study that had worked for Pfizer, called ASAP, conducted by John Kastelein of the University of the Netherlands.

FORBES: Vytorin On Trial

Then he urges Weiner's colleague, Norbert Schuff, to include a subset of patients not yet on medication in a brain-imaging study Schuff is doing.

FORBES: Magazine Article